Lexicon Pharmaceuticals Research and Development Day Webcast
December 03 2007 - 8:00AM
PR Newswire (US)
Webcast Alert: Lexicon Pharmaceuticals, Inc. Announces Webcast of
Annual Research & Development Day THE WOODLANDS, Texas, Dec. 3
/PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc.
(NASDAQ:LXRX) announces the following Webcast: What: Lexicon
Pharmaceuticals Research and Development Day Webcast When:
Wednesday, December 5th @ 12 Noon, Eastern Where: Webcast link will
be available at http://www.lexpharma.com/ or at
http://www.videonewswire.com/event.asp?id=44188 How: Live over the
Internet -- Simply log on to the web at the address above, or by
using the link at Lexicon's website. If you are unable to
participate during the live Webcast, the call will be archived on
the Web site, http://www.lexpharma.com/, until December 12, 2007.
Lexicon is a biopharmaceutical company focused on the discovery and
development of breakthrough treatments for human disease. Lexicon
currently has clinical programs underway for such areas of major
unmet medical need as irritable bowel syndrome and cognitive
disorders. The company has used its proprietary gene knockout
technology to discover more than 100 promising drug targets and
create an extensive pipeline of clinical and preclinical programs
in the therapeutic areas of diabetes and obesity, cardiovascular
disease, psychiatric and neurological disorders, cancer, immune
system disorders and ophthalmic disease. To advance the development
and commercialization of its programs, Lexicon is working both
independently and through collaborators including Bristol-Myers
Squibb Company, Genentech, Inc. and N.V. Organon. For additional
information about Lexicon and its programs, please visit
http://www.lexpharma.com/. DATASOURCE: Lexicon Pharmaceuticals
CONTACT: Bobbie Faulkner of Lexicon Pharmaceuticals,
+1-281-863-3503 Web site: http://www.lexpharma.com/
Copyright
Lexicon Pharmaceuticals (NASDAQ:LXRX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Lexicon Pharmaceuticals (NASDAQ:LXRX)
Historical Stock Chart
From Jul 2023 to Jul 2024